About Us Strategy & Mission Our Values Our People Our Board Our Scientific Advisors Our Collaborations Contact Our Programs Pipeline C. difficile Infection Enterobacteriaceae Clinical Trials Our Science Discuva Platform Scientific Literature & Publications Investors Investor Center Press Releases Financial Reports & Filings Email Alerts Share Price Data Analyst Coverage Corporate Governance Shareholder Meetings Careers
Press Releases Our latest press releases are available to read in this section Press Releases Date Range Explore Search Press Releases / 19 Aug 2020 Summit Announces Results of Court Meeting and General Meeting Press Releases / 16 Jul 2020 Summit Announces Intention to Redomicile its Holding Company to the United States Press Releases / 13 Jul 2020 Publication of Phase 2 Clinical Analyses of Gut Microbiome Health Press Releases / 08 Jun 2020 Summit Appoints Michael Donaldson as Chief Financial Officer Press Releases / 02 Jun 2020 Financial Results and Operational Progress for the First Quarter and Three Months Ended March 31, 2020 Press Releases / 30 Apr 2020 Results for Fourth Period and Eleven Months Ended December 31, 2019 Press Releases / 14 Apr 2020 Summit Appoints Robert W. Duggan as Chief Executive Officer Press Releases / 26 Feb 2020 Summit Appoints Robert W. Duggan as Executive Chairman Press Releases / 06 Feb 2020 Summit Therapeutics to Receive $1.0 Million Milestone Payment from Eurofarma Press Releases / 23 Jan 2020 Summit Announces BARDA Expands Ridinilazole Award by $8.8 Million to Include Additional NDA-Enabling Work Press Releases / 07 Jan 2020 Summit Therapeutics Launches Online Resource for Patients with C. difficile Infection Press Releases / 17 Dec 2019 Financial Results for the Third Quarter Ended 31 October 2019 << 1 2 3 … 28 29 >>
Press Releases / 19 Aug 2020 Summit Announces Results of Court Meeting and General Meeting Press Releases / 16 Jul 2020 Summit Announces Intention to Redomicile its Holding Company to the United States Press Releases / 13 Jul 2020 Publication of Phase 2 Clinical Analyses of Gut Microbiome Health Press Releases / 08 Jun 2020 Summit Appoints Michael Donaldson as Chief Financial Officer Press Releases / 02 Jun 2020 Financial Results and Operational Progress for the First Quarter and Three Months Ended March 31, 2020 Press Releases / 30 Apr 2020 Results for Fourth Period and Eleven Months Ended December 31, 2019 Press Releases / 14 Apr 2020 Summit Appoints Robert W. Duggan as Chief Executive Officer Press Releases / 26 Feb 2020 Summit Appoints Robert W. Duggan as Executive Chairman Press Releases / 06 Feb 2020 Summit Therapeutics to Receive $1.0 Million Milestone Payment from Eurofarma Press Releases / 23 Jan 2020 Summit Announces BARDA Expands Ridinilazole Award by $8.8 Million to Include Additional NDA-Enabling Work Press Releases / 07 Jan 2020 Summit Therapeutics Launches Online Resource for Patients with C. difficile Infection Press Releases / 17 Dec 2019 Financial Results for the Third Quarter Ended 31 October 2019
Press Releases / 16 Jul 2020 Summit Announces Intention to Redomicile its Holding Company to the United States
Press Releases / 02 Jun 2020 Financial Results and Operational Progress for the First Quarter and Three Months Ended March 31, 2020
Press Releases / 06 Feb 2020 Summit Therapeutics to Receive $1.0 Million Milestone Payment from Eurofarma
Press Releases / 23 Jan 2020 Summit Announces BARDA Expands Ridinilazole Award by $8.8 Million to Include Additional NDA-Enabling Work
Press Releases / 07 Jan 2020 Summit Therapeutics Launches Online Resource for Patients with C. difficile Infection
